THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)

Juvenile myoclonic epilepsy (JME) (Janz syndrome) is a form of idiopathic generalized epilepsy (IGE) of adolescence, which is characterized by massive bilateral myoclonic seizures occurring predominantly in the arms on awakening from sleep. A Proposed Diagnostic Scheme for People with Epileptic Seiz...

Full description

Saved in:
Bibliographic Details
Main Authors: O. V. Belyaev, E. A. Volkova
Format: Article
Language:Russian
Published: ABV-press 2015-06-01
Series:Русский журнал детской неврологии
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/52
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339078385860608
author O. V. Belyaev
E. A. Volkova
author_facet O. V. Belyaev
E. A. Volkova
author_sort O. V. Belyaev
collection DOAJ
description Juvenile myoclonic epilepsy (JME) (Janz syndrome) is a form of idiopathic generalized epilepsy (IGE) of adolescence, which is characterized by massive bilateral myoclonic seizures occurring predominantly in the arms on awakening from sleep. A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy (2001) refers JME to a group of IGE with a variable phenotype. JME is one of the most com- mon forms of epilepsy (7 % among all forms of epilepsy and 27 % among its all idiopathic forms). The authors describe the history of epilepsy, the specific features of the course of the disease, its clinical manifestations, the characteristic types of seizures, and approaches to diagnosis and therapy. They also proposed the results of their investigation, the aim of study were epidemiological pattern of JME and the specific features of its therapy and remission in the Volgograd Region. The investigation showed that 83 % of the patents with JME in the Volgograd Region could achieve remission with medical treatment, as shown by the EpiCenter. Valproates are the drugs of choice (remission was achieved in 92 %). The most common combination was levetiracetam and valproate (71 % remission). Complete clinical and electroencephalographic remission of JME was achieved in 41 % of cases, valproates therewith remain to have benefits too (58 % remission).
format Article
id doaj-art-c441cc8136f14cf89556ade1fe9f508f
institution Kabale University
issn 2073-8803
2412-9178
language Russian
publishDate 2015-06-01
publisher ABV-press
record_format Article
series Русский журнал детской неврологии
spelling doaj-art-c441cc8136f14cf89556ade1fe9f508f2025-08-20T03:44:13ZrusABV-pressРусский журнал детской неврологии2073-88032412-91782015-06-01102131810.17650/2073-8803-2015-10-2-13-1846THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)O. V. Belyaev0E. A. Volkova1EpiCenter; 14 Donetskaya St., Volgograd, 400131, RussiaEpiCenter; 14 Donetskaya St., Volgograd, 400131, RussiaJuvenile myoclonic epilepsy (JME) (Janz syndrome) is a form of idiopathic generalized epilepsy (IGE) of adolescence, which is characterized by massive bilateral myoclonic seizures occurring predominantly in the arms on awakening from sleep. A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy (2001) refers JME to a group of IGE with a variable phenotype. JME is one of the most com- mon forms of epilepsy (7 % among all forms of epilepsy and 27 % among its all idiopathic forms). The authors describe the history of epilepsy, the specific features of the course of the disease, its clinical manifestations, the characteristic types of seizures, and approaches to diagnosis and therapy. They also proposed the results of their investigation, the aim of study were epidemiological pattern of JME and the specific features of its therapy and remission in the Volgograd Region. The investigation showed that 83 % of the patents with JME in the Volgograd Region could achieve remission with medical treatment, as shown by the EpiCenter. Valproates are the drugs of choice (remission was achieved in 92 %). The most common combination was levetiracetam and valproate (71 % remission). Complete clinical and electroencephalographic remission of JME was achieved in 41 % of cases, valproates therewith remain to have benefits too (58 % remission).https://rjdn.abvpress.ru/jour/article/view/52epilepsy, idiopathic epilepsy, idiopathic generalized epilepsy, juvenile myoclonic epilepsy, janz syndrome, clinical picture, diagnosis, treatment, prognosis, remission, valproate, levetiracetam
spellingShingle O. V. Belyaev
E. A. Volkova
THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)
Русский журнал детской неврологии
epilepsy, idiopathic epilepsy, idiopathic generalized epilepsy, juvenile myoclonic epilepsy, janz syndrome, clinical picture, diagnosis, treatment, prognosis, remission, valproate, levetiracetam
title THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)
title_full THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)
title_fullStr THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)
title_full_unstemmed THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)
title_short THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)
title_sort incidence of juvenile myoclonic epilepsy and analysis of its therapy according to the data of the epicenter volgograd
topic epilepsy, idiopathic epilepsy, idiopathic generalized epilepsy, juvenile myoclonic epilepsy, janz syndrome, clinical picture, diagnosis, treatment, prognosis, remission, valproate, levetiracetam
url https://rjdn.abvpress.ru/jour/article/view/52
work_keys_str_mv AT ovbelyaev theincidenceofjuvenilemyoclonicepilepsyandanalysisofitstherapyaccordingtothedataoftheepicentervolgograd
AT eavolkova theincidenceofjuvenilemyoclonicepilepsyandanalysisofitstherapyaccordingtothedataoftheepicentervolgograd
AT ovbelyaev incidenceofjuvenilemyoclonicepilepsyandanalysisofitstherapyaccordingtothedataoftheepicentervolgograd
AT eavolkova incidenceofjuvenilemyoclonicepilepsyandanalysisofitstherapyaccordingtothedataoftheepicentervolgograd